轴性脊柱关节炎起始队列中的诊断挑战:法国国家DESIR队列的案例
DESIR是一项正在进行的法国国家多中心起始轴性脊柱关节炎队列,随访已达12.5年。在纳入的708例患者中,超过10年随访期间45例(6.4%)因诊断改变被排除,300例(42.4%)失访;基于多重插补估计失访者中42例(14.0%)初始诊断发生改变。基线放射学骶髂关节炎、银屑病、CRP≥6 mg/L、NSAID反应良好、HLA-B27阳性、前胸壁疼痛和女性是与诊断保持不变相关的因素。
要点
- DESIR队列随访12.5年,708例中45例(6.4%)因诊断改变被排除,300例(42.4%)失访。
- 基于多重插补,失访的300例中估计42例(14.0%)初始axSpA诊断发生改变。
- 基线放射学骶髂关节炎(OR 17.0)、银屑病(OR 5.3)、CRP≥6 mg/L(OR 2.7)等与诊断不变相关。
核心结论
- 这些数据提示近期起病的axSpA存在诊断改变,但不频繁,且基线存在客观特征时诊断改变的可能性较小。
研究设计与样本
- DESIR是一项正在进行的法国国家多中心起始axSpA队列,目前随访12.5年。
- 入组时及每次访视确认的axSpA诊断基于治疗风湿科医生的意见;若初始诊断改变则中断随访。
- 采用多重插补估计失访患者初始axSpA诊断改变的概率,并在插补数据集上使用多变量logistic回归模型评估与诊断不变相关的因素。
主要发现
- 纳入708例患者,超过10年随访期间45例(6.4%)因诊断改变被排除,300例(42.4%)失访。
- 基于300例失访者的插补,估计其中42例(14.0%)初始axSpA诊断发生改变。
- 与随访期间初始axSpA诊断不变相关的因素(OR(95%CI)):放射学骶髂关节炎17.0(4.1至71.0);银屑病5.3(2.0至14.3);CRP≥6 mg/L 2.7(1.3至5.3);NSAID反应良好2.5(1.5至4.2);HLA-B27阳性2.0(1.3至3.3);前胸壁疼痛2.0(1.2至3.3);女性1.9(1.2至3.0)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inception cohorts aim to describe chronic diseases from diagnosis and over years of follow-up. Axial spondyloarthritis (axSpA) diagnosis might be challenging during the first years of the disease. Thus, identifying the features that will be associated with a confirmed diagnosis over time is key. OBJECTIVES: To assess the frequency and the predisposing factors for a change of an initial diagnosis in an inception axSpA cohort. METHODS: DESIR is an ongoing national multicentre inception axSpA cohort with currently 12.5 years of follow-up. At the entry visit and confirmed at each visit, the diagnosis of axSpA was based on the opinion of the treating rheumatologist. Follow-up was interrupted in case of a change in this initial diagnosis. Multiple imputation was used to estimate the probability of a change in the initial diagnosis of axSpA for each patient lost to follow-up. Factors predisposing to an unchanged diagnosis of axSpA were then assessed using a multivariate logistic regression model on the imputed data sets. RESULTS: Of the 708 patients included, over 10 years of follow-up, 45 (6.4%) were excluded due to a diagnosis change and 300 (42.4%) patients were lost to follow-up. Based on the imputation of these 300 patients, a change in their initial axSpA diagnosis was estimated in 42 (14.0%). Factors predisposing to an unchanged initial axSpA diagnosis during follow-up were (ORs (95% CIs)): radiographic sacroiliitis: 17.0 (4.1 to 71.0); psoriasis: 5.3 (2.0 to 14.3); CRP≥6 mg/L: 2.7 (1.3 to 5.3); good NSAID response: 2.5 (1.5 to 4.2); HLA B27+: 2.0 (1.3 to 3.3); anterior chest wall pain: 2.0 (1.2 to 3.3) and female sex: 1.9 (1.2 to 3.0). CONCLUSION: These data suggest that a change in diagnosis in recent onset axSpA exists, but is not frequent, and is less likely to occur in the presence of objective features at baseline.
引用
- Molto A, Serrand C, Alonso S, et al. Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort. RMD Open. 2024. PMID: 39043614. doi:10.1136/rmdopen-2024-004484
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。